Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TCR-T CELL THERAPY TARGETING EPSTEIN-BARR VIRUS
Document Type and Number:
WIPO Patent Application WO/2021/243695
Kind Code:
A1
Abstract:
Provided are T cell receptors that recognize or bind to Epstein-Barr virus (EBV) antigens, genetically engineered cells, and cell-based therapies.

Inventors:
WU HAIYANG (CN)
ZHOU JIE (CN)
DENG DACHUAN (CN)
LI SI (US)
ZHAO LIXIA (US)
ZHANG LU (US)
CHEN RUI (US)
BRYSON PAUL (US)
MUDGAL POORVA PRAKASH (US)
Application Number:
PCT/CN2020/094628
Publication Date:
December 09, 2021
Filing Date:
June 05, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGDONG TCRCURE BIOPHARMA TECH CO LTD (CN)
TCRCURE BIOPHARMA CORP (US)
International Classes:
C07K14/725; A61K38/17; A61P35/00; C07K16/08; C12N15/867
Domestic Patent References:
WO2020082130A12020-04-30
WO2019161133A12019-08-22
WO2011039508A22011-04-07
WO2019033057A12019-02-14
WO2016095783A12016-06-23
Foreign References:
EP3494984A12019-06-12
CN109306005A2019-02-05
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: MINERAL OIL BASED DRY LUBRICANT FOR PLASTIC CONVEYORS

Next Patent: VEHICLE NAVIGATION POSITIONING METHOD AND APPARATUS, AND BASE STATION, SYSTEM AND READABLE STORAGE M...